|
RNF13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.9591000000061E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.211300E-04 |
| Normal-vs-Stage2 |
5.382400E-03 |
| Normal-vs-Stage3 |
2.68120000002092E-06 |
| Normal-vs-Stage4 |
3.02160000020812E-07 |
| Stage1-vs-Stage2 |
8.835800E-01 |
| Stage1-vs-Stage3 |
4.635800E-02 |
| Stage1-vs-Stage4 |
1.198070E-02 |
| Stage2-vs-Stage3 |
2.243400E-01 |
| Stage2-vs-Stage4 |
5.914500E-02 |
| Stage3-vs-Stage4 |
3.434400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.14019999997161E-06 |
| Normal-vs-AfricanAmerican |
1.783550E-02 |
| Normal-vs-Asian |
4.598400E-02 |
| Caucasian-vs-AfricanAmerican |
4.585800E-01 |
| Caucasian-vs-Asian |
3.594300E-02 |
| AfricanAmerican-vs-Asian |
4.818200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.59909999999375E-05 |
| Normal-vs-Female |
1.583960E-04 |
| Male-vs-Female |
3.507000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.079200E-03 |
| Normal-vs-Age(41-60Yrs) |
6.29569999999191E-05 |
| Normal-vs-Age(61-80Yrs) |
1.75579999994735E-06 |
| Normal-vs-Age(81-100Yrs) |
3.605500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.701000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.784400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.893600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.457200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.366000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.435400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.290000E-02 |
| Classical-VS-Follicular |
2.414000E-01 |
| Classical-VS-Other |
3.743000E-01 |
| Classical-VS-Normal |
1.009020E-04 |
| Tall-VS-Follicular |
4.284200E-03 |
| Tall-VS-Other |
8.135200E-01 |
| Tall-VS-Normal |
1.6963000000203E-06 |
| Follicular-VS-Other |
2.750000E-01 |
| Follicular-VS-Normal |
2.290500E-02 |
| Other-VS-Normal |
1.095530E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.45879999999966E-05 |
| Normal-vs-N1 |
1.80113000000093E-05 |
| N0-vs-N1 |
1.203810E-01 |
|
|
